Abstract
The prospects of enhancing cognitive or motor functions using neuroscience in otherwise healthy individuals has attracted considerable attention and interest in neuroethics (Farah et al., Nature Reviews Neuroscience 5:421–425, 2004; Glannon Journal of Medical Ethics 32:74–78, 2006). The use of stimulants is one of the areas which has propelled the discussion on the potential for neuroscience to yield cognition-enhancing products. However, we have found in our review of the literature that the paradigms used to discuss the non-medical use of stimulant drugs prescribed for attention deficit/hyperactivity disorder (ADHD) vary considerably. In this brief communication, we identify three common paradigms—prescription drug abuse, cognitive enhancement, and lifestyle use of pharmaceuticals—and briefly highlight how divergences between paradigms create important “ethics blind spots”.
Notes
In this paper, we use the term “non-medical use” to: (1) reflect the fact that the uses we refer to are not medically approved and (2) take some distance from the prescription drug abuse and cognitive enhancement paradigms that we are discussing.
References
Anonymous. 2007. Enhancing, not cheating. Nature 450: 320.
British Medical Association. 2007. Boosting your brainpower: Ethical aspects of cognitive enhancement. 42. London, UK: British Medical Association.
Chatterjee, A. 2007. Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges. Cambridge Quarterly of Healthcare Ethics 16: 129–137.
Farah, M.J., J. Illes, R. Cook-Deegan, H. Gardner, E. Kandel, P. King, E. Parens, B. Sahakian, and P.R. Wolpe. 2004. Neurocognitive enhancement: what can we do and what should we do? Nature Reviews Neuroscience 5: 421–425.
Garreau, J. 2006. ‘Smart pills’ are on the rise. But is taking them wise? The Washington Post. June 11: D01.
Glannon, W. 2006. Psychopharmacology and memory. Journal of Medical Ethics 32: 74–78.
Hall, K.M., M.M. Irwin, K.A. Bowman, W. Frankenberger, D.C. Jewett. 2005. Illicit use of prescribed stimulant medication among college students. Journal of American College Health 53: 167–174.
Khan, M. 2003. Study drugs draw concern. The Miami Herald. July 6: 1BR.
Laurance, J. 2003. Abuse hits students looking for an exam kick. The Independent. August 26: 5.
Low, K.G., A.E. Gendaszek. 2002. Illicit use of psychostimulants among college students: a preliminary study. Psychology, Health & Medicine 7: 283–287.
Maher, B. 2008. Poll results: look who’s doping. Nature 452: 674–675.
National Institute on Drug Abuse. 2005. Prescription drugs: Abuse and addiction. Research report series. National Institute on Drug Abuse: 12 p.
Phillips, S. 2006. An espresso at three in the morning is just so last year. The Times Higher Education Supplement. March 10: 18.
President’s Council on Bioethics. 2003. Beyond therapy. President’s Council on Bioethics/Harper Collins: Washington, D.C., 328 p.
Prudhomme White, B., K.A. Becker-Blease, K. Grace-Bishop. 2006. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. Journal of American College Health 54: 261–268.
Teter, C.J., S.E. McCabe, J.A. Cranford, C.J. Boyd, S.K. Guthrie. 2005. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 53: 253–262.
Teter, C.J., S.E. McCabe, K. LaGrange, J.A. Cranford, C.J. Boyd. 2006. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26: 1501–1510.
Wilens, T.E., L.A. Adler, J. Adams, et al. 2008. Misuse and diversion of stimulants prescribes for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 47: 21–31.
Zernike, K. 2005. The difference between steroids and Ritalin is. The New York Times. March 20: 3.
Acknowledgments
We would like to acknowledge the support of the International Institute for Research in Ethics and Biomedicine, the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council of Canada, and the Institut de recherches cliniques de Montréal. Thanks to Nicole Palmour, Dr. Emily Bell, and Dr. David Bouvier. The authors report no conflicts of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Racine, E., Forlini, C. Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?. Neuroethics 3, 1–4 (2010). https://doi.org/10.1007/s12152-008-9023-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12152-008-9023-7